Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study

Takehiro Tozuka, Yoko Tsukita, Kohei Kushiro, Shinobu Hosokawa, Hitomi Nogawa, Satoshi Arai, Sayo Soda, Daisuke Arai, Kei Takamura, Ryoichi Honda, Kosuke Hamai, Yukiko Namba, Yasutaka Kawai, Takashi Kikuchi, Kensuke Nakazawa, Takayuki Honda, Noriyuki Ebi, Yutaka Yamada, Tomonori Makiguchi, Masahiro Seike, Satoshi Morita, Kunihiko Kobayashi, Hajime Asahina

Open source

DOI: 10.1007/s10147-025-02911-1
Published: 2025-11-05
Container: International Journal of Clinical Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10147-025-02911-1,
  title = {Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study},
  author = {Takehiro Tozuka and Yoko Tsukita and Kohei Kushiro and Shinobu Hosokawa and Hitomi Nogawa and Satoshi Arai and Sayo Soda and Daisuke Arai and Kei Takamura and Ryoichi Honda and Kosuke Hamai and Yukiko Namba and Yasutaka Kawai and Takashi Kikuchi and Kensuke Nakazawa and Takayuki Honda and Noriyuki Ebi and Yutaka Yamada and Tomonori Makiguchi and Masahiro Seike and Satoshi Morita and Kunihiko Kobayashi and Hajime Asahina},
  year = {2025},
  journal = {International Journal of Clinical Oncology},
  doi = {10.1007/s10147-025-02911-1},
  url = {https://doi.org/10.1007/s10147-025-02911-1}
}

RIS

TY  - JOUR
TI  - Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study
AU  - Takehiro Tozuka
AU  - Yoko Tsukita
AU  - Kohei Kushiro
AU  - Shinobu Hosokawa
AU  - Hitomi Nogawa
AU  - Satoshi Arai
AU  - Sayo Soda
AU  - Daisuke Arai
AU  - Kei Takamura
AU  - Ryoichi Honda
AU  - Kosuke Hamai
AU  - Yukiko Namba
AU  - Yasutaka Kawai
AU  - Takashi Kikuchi
AU  - Kensuke Nakazawa
AU  - Takayuki Honda
AU  - Noriyuki Ebi
AU  - Yutaka Yamada
AU  - Tomonori Makiguchi
AU  - Masahiro Seike
AU  - Satoshi Morita
AU  - Kunihiko Kobayashi
AU  - Hajime Asahina
PY  - 2025
JO  - International Journal of Clinical Oncology
DO  - 10.1007/s10147-025-02911-1
UR  - https://doi.org/10.1007/s10147-025-02911-1
ER  -

APA

Tozuka, T., Tsukita, Y., Kushiro, K., Hosokawa, S., Nogawa, H., Arai, S., Soda, S., Arai, D., Takamura, K., Honda, R., Hamai, K., Namba, Y., Kawai, Y., Kikuchi, T., Nakazawa, K., Honda, T., Ebi, N., Yamada, Y., Makiguchi, T., Seike, M., Morita, S., Kobayashi, K., & Asahina, H. (2025). Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02911-1

Source records

crossref · retrieved 2026-09-26T19:19:41.224Z